Literature DB >> 3001491

Chemotherapy of primary brain tumors.

V A Levin.   

Abstract

This article covers chemotherapy of malignant astrocytomas, ependymoma, and medulloblastoma. The future direction of anticancer drugs is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001491

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  12 in total

1.  Effect of HECNU in malignant supratentorial gliomas--a phase II study.

Authors:  P Georges; S Przedborski; J Brotchi; M Chatel; D Gédouin; J Hildebrand
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

2.  Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.

Authors:  C Liu; B F Kimler; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

Review 3.  Practical guidelines for the treatment of malignant gliomas.

Authors:  M C Chamberlain; P A Kormanik
Journal:  West J Med       Date:  1998-02

4.  Chemotherapy for advanced CNS ependymoma.

Authors:  M K Gornet; J C Buckner; R S Marks; B W Scheithauer; B J Erickson
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy.

Authors:  J M Piepmeier; P E Pedersen; D Yoshida; C Greer
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

Review 6.  Malignant gliomas of the cerebellum: an analytic review.

Authors:  H R Djalilian; W A Hall
Journal:  J Neurooncol       Date:  1998-02       Impact factor: 4.130

7.  Fourth ventricle ependymomas. A study of 20 cases with survival analysis.

Authors:  L Ferrante; L Mastronardi; G Schettini; P Lunardi; A Fortuna
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  The history of ependymoma management.

Authors:  Kyu-Won Shim; Dong-Seok Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2009-05-21       Impact factor: 1.475

9.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.

Authors:  C Ghosh; H M Lazarus; J S Hewlett; R J Creger
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.